Vielbeachtet, vielzitiert
advanceCOR ist ein forschungsstarkes Unternehmen. Unsere Wissenschaftler publizieren ihre Ergebnisse regelmäßig in renommierten Fachjournalen.
2020
Sara Alberti, Qianqian Zhang, Ilaria D’Agostino, Annalisa Bruno, Stefania Tacconelli, Annalisa Contursi, Simone Guarnieri, Melania Dovizio,
Lorenza Falcone, Patrizia Ballerini, Götz Münch, Ying Yu & Paola Patrignani. The antiplatelet agent revacept prevents the increase of systemic thromboxane A2 biosynthesis and neointima hyperplasia. nature research Scientific Reports | (2020) 10:21420 – Artikel online lesen oder hier als PDF lesen
Gröschel K, Uphaus T, Loftus I., Poppert H, Diener HC, Zobel J, Münch G. Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Artery Stenosis: Design and Rationale of a Randomized Phase II Clinical Trial. Volume 04, Number 04 of TH Open – Artikel online lesen oder Artikel hier als PDF lesen
2019
Zeibig S, Büttcher M, Goebel S, Pauli J, Hunger A, Ungerer M, Gawaz M Münch G. The Scavenger Receptor CD68 Regulates Platelet Mediated Oxidized Low-Density Lipoprotein (oxLDL) Deposition in Atherosclerotic Vessels at an Early Stage of Atherosclerosis in LDLR-/-/ApoBec-/- Mice. Cell Physiol Biochem 2019;52;681-695 – Artikel online lesen oder hier als PDF lesen
Faßbender J, Holthoff HP, Li Z, Ungerer M. Therapeutic Effects of Short Cyclic and Combined Epitope Peptides in a Long-Term Model of Graves’ Disease and Orbitopathy. THYROID Volume 29, Number 2, 2019 – Artikel hier als PDF lesen
2018
Boivin-Jahns V, Uhland K, Holthoff H-P,Beyersdorf N, Kocoski V, Kerkau T, Münch G, Lohse M. Ungerer M, Jahns R. Cyclopeptide COR-1 to treat beta1-adrenergicreceptor antibody-induced heart failure. PLoS ONE13(8): publ Aug 20, 2018 – Artikel hier als PDF lesen
2017
Holthoff HP, Li Z, Faßbender J, Reimann Adler K, Münch G, Ungerer M, Cyclic Peptides for effective treatment in a long term model of Graves Disease and Orbitopathie in female mice , Endocrinology 158:1-16, 2017 – Artikel als PDF lesen
Mojica Muñoz AK, Jamasbi J, Uhland K, Degen H, Münch G, Ungerer M, Megens R, Weber C, Lorenz R, Brandl R, Siess W. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation. Thromb Haemost. 2017; 117(8):1651-1659 – Artikel online lesen
Degen H, Borst O, Ziegler M, Mojica Munoz AK, Jamasbi J, Walker B, Göbel S, Fassbender J, Adler K, Brandl R, Münch G, Lorenz R, Siess W, Gawaz M, Ungerer M. ADPase CD 39 fused to glycoprotein VI boosts local anti-thrombotic effects at vascular lesions. J Am Heart Ass 2017, 6:e005991; as of July 27, 2017 – Artikel online lesen oder hier als PDF lesen
2016
Ungerer M, Faßbender J, Li Z, Münch G, Holthoff HP. Review of Mouse Models of Graves’ Disease and Orbitopathy—Novel Treatment by Induction of Tolerance. Clinic Rev Allerg Immunol /2016-016-8562-7 – Artikel als PDF lesen
Baumgartner C, Brandl J, Münch G, , Ungerer M. Rabbit models to study atherosclerosis and its complications e Transgenic vascular protein expression in vivo Progress in Biophysics and Molecular Biology 121 (2016) 131e141 – Artikel online lesen
2015
Kommentiert in: Kleiman NS; Kolandaivelu K. Expanding the Roster : Developing New Inhibitors of Intravascular Thrombosis. J Am Coll Cardiol 2015; 65 (22): 2416 – 2419 – Artikel online lesen
Jamasbi J, Megens RTA, Bianchini M, Münch G, Ungerer M, Faussner A, Sherman S, Walker A, Goyal P, Jung S, Brandl R, Weber C, Lorenz R, Elia N, Farndale J, Siess W. Differential inhibition of human atherosclerotic plaque- induced platelet activation by dimeric GPVI-Fc and anti-GPVI antibodies: functional and imaging studies. J Am Coll Cardiol 2015; 65 (22): 2404-2415 – Artikel online lesen
Holthoff HP, Goebel S, Li Z, Faßbender J,Reimann A, Zeibig S, Lohse M, Münch G, Ungerer M. Prolonged TSH Receptor A Subunit Immunization of Female Mice Leads to a Long-Term Model of Graves’Disease, Tachycardia, and Cardiac Hypertrophy. Endocrinology, April 2015, 156(4):1577–1589 – Artikel als PDF lesen
2013
Ungerer M, Münch G. Novel antiplatelet drugs in clinical development. Thromb Haemost 2013; 110 – Artikel online lesen
Dovizio M, Maier TH, Alberti S, Di Francesco L, Marcantoni E, Münch G, John C, Suess B, Sgambato A, Steinhilber D, Patrignani P. Pharmacological Inhibition of Platelet-Tumor Cell Cross-Talk Prevents Platelet-Induced Overexpression of Cyclooxygenase-2 in HT29 Human Colon Carcinoma Cells. Mol Pharmacol 84:25–40, July 2013 – Artikel als PDF lesen
Ungerer M, Li ZM, Baumgartner C, Göbel S, Vogelmann J, Holthoff HP, Bültmann A, Gawaz M, Münch G. The GPVI – Fc fusion protein Revacept reduces thrombus formation and improves vascular dysfunction in atherosclerosis without any impact on bleeding times. PLOS ONE 2013; 8(8):e71193 – Artikel online lesen
Göbel S, Li ZM, Vogelmann J, Holthoff HP, Degen H, Hermann DM, Gawaz M, Ungerer M, Münch G. The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke. PLOS ONE 2013, 8(7):e66960 – Artikel online lesen
2010 - 2012
Baumer Y, Leder C, Ziegler M, Schönberger T, Ochmann C, Perk A, Degen H, Schmid-Horch B, Elvers M, Münch G, Ungerer M, Schlosshauer B, Gawaz M. The recombinant bifunctional protein aCD133–GPVI promotes repair of the infarcted myocardium in mice. J Thromb Haemost 2012; 10: 1152–64 – Artikel als PDF lesen
Bültmann A, Li Z, Wagner S, Peluso M, Schönberger T, Weis C, Konrad I, Stellos K, Massberg S, Nieswandt B, Gawaz M, Ungerer M, Münch G. Impact of glycoprotein VI and platelet adhesion on atherosclerosis–a possible role of fibronectin. J Mol Cell Cardiol 2010; 49(3):532-42 – Artikel online lesen
Zeibig S, Li Z, Wagner S, Holthoff HP, Ungerer M, Bültmann A, Uhland K, Vogelmann J, Simmet T, Gawaz M, Münch G. Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis. Circulation Research 2011; 108:695-703 – Artikel online lesen
Ungerer M, Rosport K, Bültmann A, Piechatzek R, Uhland K, Schlieper P, Gawaz M, Münch G. The novel anti-platelet drug Revacept (dimeric GPVI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general haemostasis in humans. Circulation 2011; 123: 1891-1899. – Artikel online lesen
Bültmann A, Li Z, Wagner S, Gawaz M, Ungerer M, Langer H, May A, Münch G. Loss of protease activity of ADAM15 abolishes protective effects on plaque progression in atherosclerosis. Int J Cardiol 152_2011 pp. 382-385 – Artikel als PDF lesen
Holthoff HP, Zeibig S, Jahns-Boivin V, Bauer J, Lohse M, Kääb S, Clauss S, Jahns R, Schlipp A, Münch G, Ungerer M. Detection of Anti–β1-AR Autoantibodies in Heart Failure by a Cell-Based Competition ELISA. Circulation Research. 2012;111:675–684 – Artikel online lesen oder hier als PDF lesen